The four-year 6M€ European project iHIVARNA, funded by the European Commission, aims to successfully immunize antiretroviral-treated HIV-infected pat1
Neurodegenerative diseases are chronic and still lacking an effective treatment, so they have become a growing concern in our aging society. The lack1
IDIBAPS, in addition to working in disease prevention from a research perspective, is actively involved in activities oriented to society. Recently i1
The Translational Research group in Posttransplant Neoplasia, led by Dr. Ignacio Revuelta, started up at the IDIBAPS in January 2012. After his stay1
We are at the gates of Horizon 2020, the new framework program of the European Commission, which will regulate the period 2014-2020. The Health Conne1
Micro RNAs were on the study focus during the November 25th IDIBAPS Seminar, offerd by Dr. Markus Stoffel, from the Institute of Molecular Health Sci1
Dr. Elías Campo is one of the most prominent researchers at IDIBAPS and Professor of Pathology at the University of Barcelona. He combines the positi1
Hospital Clínic of Barcelona today announced results from their collaboration with Siemens Healthcare to use advanced laboratory and imaging technol1
Dr. Thaís Armangué, pediatric neurology specialist at the IDIBAPS’ Neuroimmunology Program, received this afternoon the First accesit of the 2013 Mut1
